Marulanda Juliana, Alqarni Saleh, Murshed Monzur
1529 Cedar Avenue, Montreal, Quebec H3G 1A4, Canada.
Curr Pharm Des. 2014;20(37):5801-10. doi: 10.2174/1381612820666140212205848.
Mineralization of bone and tooth extracellular matrix (ECM) is a physiologic process, while soft tissue mineralization, also known as ectopic mineralization (calcification), is a pathologic condition. Vascular calcification is common in aging and also in a number of genetic and metabolic disorders. The calcific deposits in arteries complicate the prognosis and increase the morbidity in diseases such as atherosclerosis, diabetes and chronic kidney disease (CKD). To completely understand the pathophysiology of these lifethreatening diseases, it is critical to elucidate the molecular mechanisms underlying vascular calcification. Unveiling these mechanisms will eventually identify new therapeutic targets and also improve the management of the associated complications. In the current review, we discussed the common determinants of ECM mineralization, the mechanism of vascular calcification associated with several human diseases and outlined the most common therapeutic approaches to prevent its progression.
骨骼和牙齿细胞外基质(ECM)的矿化是一个生理过程,而软组织矿化,也称为异位矿化(钙化),则是一种病理状态。血管钙化在衰老过程中以及许多遗传和代谢紊乱中都很常见。动脉中的钙化沉积物会使诸如动脉粥样硬化、糖尿病和慢性肾脏病(CKD)等疾病的预后复杂化并增加发病率。为了全面了解这些危及生命的疾病的病理生理学,阐明血管钙化背后的分子机制至关重要。揭示这些机制最终将确定新的治疗靶点,并改善相关并发症的管理。在本综述中,我们讨论了ECM矿化的常见决定因素、与几种人类疾病相关的血管钙化机制,并概述了预防其进展的最常见治疗方法。